In 2010, Boston will be home to a $20 million study on the effects vitamin D and fish oil have in reducing the risks of cancer and cardiovascular disease in humans, reports the Boston Globe.
In 2010, Boston will be home to a $20 million study on the effects vitamin D and fish oil have in reducing the risks of cancer and cardiovascular disease in humans, reports the Boston Globe. The project is being funded by NIH (Bethesda, MD), and will enroll 20,000 patients starting January of next year.
The intentions of the study are to analyze how vitamin D affects the average person, and specifically how it affects African American. Darker skin does prevent significant vitamin D absorption from the sun, so a quarter of the study’s patients will be black to evaluate this factor.
“African Americans have a higher risk of vitamin D deficiency and a greater frequency of certain types of cancer,” said JoAnn Manson, MD, a lead researcher for the study. “I think that it will be of great importance to look at whether something as simple as taking a vitamin D supplement can narrow these health gaps.”
The study will use women over 65 and men over 60, all with no history of cancer or cardiovascular disease. Patients will be separated into four groups-one given pills of vitamin D and fish oil, one given placebos, and the other two given one placebo and one supplement.
More information on the study can be found at www.vitalstudy.org.
Meta-analysis does not find increased risk of bleeding events from omega-3 PUFA consumption
July 8th 2024Researchers reviewed 11 studies and found that there was no difference in the incidence of bleeding events between patients receiving omega-3 PUFAs and those not receiving them. High dose EPA consumption was associated with an elevated but modest risk.
Recent review states that pentadecanoic acid may support cellular stability for better longevity
June 25th 2024According to the paper’s author, Stephanie Venn-Watson, DVM, MPH, deficiency in pentadecanoic acid of ≤0.2% total circulating fatty acids increases the risk of ferroptosis, which a type of cell death cause by the peroxidation of fragile fatty acids in cell membranes that combines with iron thus increasing reactive oxygen species, and disabling mitochondria.
Recent review makes the case for testing omega-3 fatty acid levels in humans
May 23rd 2024The article commissioned by The Global Organization for EPA and DHA Omega-3s (GOED) reviewed the state of omega-3 fatty acid testing, highlighting the value of testing and the commercially available options for diagnostic testing.
Epax launches concentrated oil that combines omegas 3, 9, and 11
May 10th 2024The blend of long-chain polyunsaturated fatty acids and long-chain monounsaturated fatty acids combines the heart and brain health benefits of omegas-3s with the skin and metabolic health benefits of omegas 9 and 11.